Full-Time
Posted on 8/22/2026
Provides personalized PTSD treatments including DSR
$20 - $22/hr
Draper, UT, USA
In Person
See people who can refer or advise you
Stella Center treats PTSD with a personalized plan centered on Dual Sympathetic Reset (DSR), a Stellate Ganglion Block procedure, and other therapies. A symptom quiz using APA measures (PCL, GAD-7, PHQ) guides the treatment choices. Treatments are delivered in clinical settings and may be covered by insurance or paid out-of-pocket, with potential support from veterans’ and first responder programs. The goal is to improve PTSD care by providing targeted, evidence-informed options and expanding access for veterans and first responders.
Company Size
51-200
Company Stage
Growth Equity (Venture Capital)
Total Funding
$7M
Headquarters
Oak Brook, Illinois
Founded
2019
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Scaling patient access the right way: The Stella-Nanonets blueprint. In collaboration with Nanonets As interventional psychiatry scales, many behavioral health operators are encountering a growth constraint. Clinical innovation is accelerating, yet administrative structures remain brittle. This causes friction for both widespread access to care and scalability of advanced therapies like ketamine, TMS, SGB, and Spravato provided by clinical leaders like Stella Mental Health. Stella Mental Health, known for its technology-forward clinical model and outcome-driven approach to care, recognized early that responsible expansion required more than adding staff or layering incremental tools. It required rethinking how technology can support the entire patient journey from first engagement with patients to reimbursements post delivery of care. To align operational systems with the rising demands of its care model, Stella partnered with Nanonets Health, an agentic AI platform purpose-built for behavioral health workflows. Unlike generalized automation tools, Nanonets deploys specialized AI agents trained on behavioral health documentation, payer dynamics, and interventional treatment pathways. Together, the organizations are building an integrated technology infrastructure designed to reduce administrative friction while preserving clinical focus. Operationalizing the front door In interventional behavioral health, the first interaction often determines whether or not a patient will choose you as their trusted provider. Prospective patients frequently arrive with detailed questions about insurance eligibility, treatment modalities, coverage limitations, and timelines. When intake workflows are fragmented or delayed, dropout risk increases before care even begins. Partnering with Nanonets, Stella is embedding AI-enabled patient engagement across inbound and outbound communication channels. Beginning with scheduling, structured intake capture, and patient support, this initiative is designed to ensure that patient information is captured in a standardized, actionable format to streamline the patient's treatment journey. "Clinical capacity should not be constrained by administrative bottlenecks," says Jason Lapensee, COO at Stella Mental Health. "Our responsibility is to design operational systems that enable our teams to expand access to care without adding unnecessary complexity." Importantly, the intent is not to displace human interaction but to elevate it. By structuring routine intake and inquiry workflows through AI-supported systems, Stella enables its care teams to focus on patients in need of a higher level of support, while the AI agents answer routine treatment-related questions and manage intake concerns. Structured engagement at the front door also creates continuity between initial contact and downstream documentation, eligibility, and reimbursement processes. "Reducing friction in access is part of reducing stigma," says Jason. "If the first interaction is confusing or inconsistent, patients refuse to engage. Thoughtful structure builds trust. This is why we onboarded Nanonets to help us streamline our intake mechanisms." This approach reflects Stella's broader strategy: operationalize intelligence at the earliest point of contact rather than correcting inconsistencies later in the cycle. Standardizing documentation and coding precision As Stella expands its interventional services across multiple states and provider teams, documentation variability presents growing complexity. Differences in note structure, payer requirements, and treatment protocols can introduce downstream reimbursement challenges. Through its partnership with Nanonets Health, Stella is integrating AI-assisted documentation and coding workflows designed to function within clearly defined guardrails and confidence thresholds. Standardized encounters are structured systematically, while nuanced or ambiguous cases are escalated to billing specialists for expert oversight. "In behavioral health, small documentation inconsistencies can create significant payer friction," says Adam Erway, Head of RCM at Stella Mental Health. "By implementing purpose-built AI agents through Nanonets, we gain visibility into where variability originates and can focus our expertise on exception cases rather than repetitive corrections." This exception-based model reinforces Stella's philosophy that clinical sophistication must be matched by operational precision. "As we continue expanding advanced treatments like ketamine therapy, Spravato, SGB and TMS, our technology stack must evolve in parallel," says Michael Gershenzon, CEO at Stella Mental Health. "Clinical innovation and operational infrastructure cannot operate independently." Activating denial intelligence. Denials in behavioral health rarely occur in isolation. They often reflect upstream inconsistencies in intake data, eligibility interpretation, or documentation clarity. Rather than treating denials as a reactive billing function, Stella is leveraging denial intelligence across its workflows. By using Nanonets AI to analyze remittance behavior and payer responses, the organization is creating a feedback loop that informs upstream intake and documentation refinement. For payment transactions that meet predefined validation criteria, structured payment posting AI workflows are being used to streamline reconciliation processes, allowing specialists to focus on more intricate payer interactions and appeals. "We are building a foundation that can scale with the complexity of our care model." says Amardeep Manhas, CTO of Stella Mental Health. "Working with Nanonets enables us to embed intelligence across the revenue cycle while keeping patient experience at the center." Building ai-native infrastructure for Behavioral Health. The Stella-Nanonets Health partnership reflects a broader industry shift toward AI-native infrastructure. As payer scrutiny intensifies and administrative demands grow, incremental automation is proving insufficient. Behavioral health organizations are increasingly recognizing the need to leverage intelligence system-wide rather than layer isolated tools onto legacy processes. "Our objective is not to automate individual tasks in isolation," says Shikhar Khanna, Founding Team member of Nanonets Health. "It is to deploy specialized AI agents that understand the nuance of behavioral health workflows and function as a coordinated intelligence layer alongside forward-thinking organizations like Stella Mental Health." For Stella, the initiative remains anchored in patient access. "If we are delivering advanced clinical treatments, our operational systems must be equally advanced," Amardeep adds. "Expanding access should not mean expanding friction." As additional agentic workflows are implemented and live performance insights mature, Stella intends to refine its infrastructure through measurable data and continuous iteration. The long-term objective is clear: ensure that administrative complexity never becomes a barrier to transformative care. In an environment defined by rising administrative overheads and payer scrutiny, the Stella-Nanonets partnership signals a structural shift in behavioral health; one where intelligence is operationalized end to end, enabling scale without compromising the patient journey. At the Becker's Fall Behavioral Health Summit, taking place October 20-22 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now. The future of clinical judgment: keeping care human-centric in the AI era. Recommended Live Webinar on May 13, 2026 12:00 PM - 1:00 PM CDT Next up in Behavioral Health news. * 'Integration only works if data lives in the same system': How 5 systems are operationalizing behavioral health Behavioral health leaders at five health systems are driving a shift toward upstream integration through operational redesign. Their goals: embedding... By: Ella Ruder * Inside UHS' playbook for responsible behavioral health growth Marc Miller, president and CEO of King of Prussia, Pa.-based Universal Health Services, leads one of the nation's largest behavioral... By: Ella Ruder * American Dental Association adds mental health, GLP-1 prompts to patient forms The American Dental Association has updated patient health history forms to include a mental health screening question and a prompt... By: Ella Ruder
Stella Mental Health has opened its second Massachusetts location in Newton, expanding access to interventional psychiatric care in Greater Boston. The clinic offers treatments including Spravato therapy, intravenous ketamine infusions and transcranial magnetic stimulation for conditions such as depression, anxiety and PTSD. The expansion coincides with the selection of Stella's Chief Psychiatric Officer, Dr Brian Boyle, as a 2026 National Spravato Bureau Speaker by Johnson & Johnson. The Harvard-trained psychiatrist, who specialises in treatment-resistant depression, will provide peer-to-peer education on innovative depression treatments. Stella Mental Health operates over 20 locations across the US, Israel and Australia, and has treated more than 40,000 patients. The company's centres offer evidence-based treatments for depression, anxiety, post-traumatic stress and OCD.
CHICAGO, April 29, 2025 /PRNewswire/ -- Since 1949, the United States has recognized May as Mental Health Awareness Month—a time to spotlight mental health conditions, break the stigma around seeking help, and connect individuals with vital resources. This year's theme, "Turn Awareness into Action," calls for meaningful steps that go beyond conversation to create real change in access and outcomes.Answering that call, Stella Mental Health is proud to announce a major initiative to expand access to care: starting May 1, 2025, Stella will substantially lower the cost of self-pay, non-insurance covered services nationwide—making innovative mental health treatments more affordable and accessible for those who need them most.This initiative comes on the heels of Stella's recent expansion into insurance-covered services, furthering the organization's mission to ensure life-saving treatments are available to as many people as possible. Stella has long recognized that cost and distance are two of the most significant barriers to accessing effective mental health care. With over 20 clinics nationwide—including five new clinics in Utah added through the recent acquisition of Numinus—Stella is committed to closing those gaps."From the very beginning, Stella has been focused on meeting people where they are—both geographically and financially," said Michael Gershenzon, CEO and Co-Founder of Stella Mental Health. "By being able to lower self-pay costs and expanding insurance coverage, we're making it easier for more people to access the high-quality care they deserve."In addition to more traditional psychiatry and therapy, Stella Mental Health offers a comprehensive range of evidence-based and science-backed biological interventions, including:An advanced Stellate Ganglion Block (SGB) for PTSD/PTSI, anxiety and long COVID called the Dual Sympathetic Reset (DSR)for PTSD/PTSI, anxiety and long COVID called the Dual Sympathetic Reset (DSR) Ketamine Infusion Therapy for depression, PTSD, and suicidality administered in officefor depression, PTSD, and suicidality administered in office Transcranial Magnetic Stimulation (TMS) —an insurance-covered, non-invasive treatment for depression and OCD—an insurance-covered, non-invasive treatment for depression and OCD SPRAVATO® (esketamine)—an insurance-covered nasal spray for treatment-resistant depressionEach treatment has been shown to provide relief where traditional therapies may have failed, giving patients renewed hope and better outcomes.These expanded treatment options come at a critical time for mental health in America. Recent data from the 2022 National Survey on Drug Use and Health reveals concerning figures about mental health:59.3 million adults (23.1% of U.S
U.S. wellness clinics sold to Stella, including a data-sharing partnership to launch a technology-driven clinic management solution for mental health care providers.Numinus Wellness clinics acquired by Stella for US$3.53 millionNuminus focusing on business units and product development ("Numinus Network") to facilitate clinic efficiency and care reimbursement for mental health practitionersStella partnering with Numinus to share operational data from its network of 12 mental health clinics, supporting the development of advanced clinic management solutions for mental health practices, including insurance reimbursement supportCreates an asset-light business with a synergistic combination of clinical support, practitioner training and clinical research with a strengthened balance sheetVANCOUVER, BC, Dec. 17, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces the closing of the previously announced definitive agreement with Stella, an interventional psychiatry practice focused on treating PTSD, anxiety and depression with biological modalities, of the sale of the Company's five Wellness Clinics in Utah for US$3.53 million."Stella and Numinus are very much aligned in terms of standards of care and a focus on optimized patient outcomes," said Michael Gershenzon, Co-Founder and CEO of Stella. "Numinus patients can look forward to the same high levels of service that the clinics are known for and an expanded offering of behavioral care. We also look forward to working with Numinus to improve clinical mental health care nationwide.""With this transaction, Numinus is re-positioning to leverage its expertise in patient care, clinic management, relationships with Insurers and now, significant access to operational data to assist clinical providers with the challenge to meet the demand of the growing number of patients seeking treatment," said Payton Nyquvest, Founder and CEO of Numinus.Numinus is developing an AI-based SaaS solution leveraging its deep patient care expertise
Significant Advancements For the Treatment of PTSD and Depression in Active Duty Military and Veteran PatientsCHICAGO, Nov. 26, 2024 /PRNewswire/ -- Stella, an interventional psychiatry practice and leading provider of science-backed therapies has partnered with Task Force Dagger, a veteran-led non-profit that focuses on the health and wellness of the active and veteran special operations community and their families. This partnership aims to support healing within the Special Operations Forces community by offering highly-effective treatments for PTSD, anxiety, depression and TBI to those in need of help